ZA939195B - Stabilized medicinal aerosol solution formulations - Google Patents
Stabilized medicinal aerosol solution formulationsInfo
- Publication number
- ZA939195B ZA939195B ZA939195A ZA939195A ZA939195B ZA 939195 B ZA939195 B ZA 939195B ZA 939195 A ZA939195 A ZA 939195A ZA 939195 A ZA939195 A ZA 939195A ZA 939195 B ZA939195 B ZA 939195B
- Authority
- ZA
- South Africa
- Prior art keywords
- solution formulations
- aerosol solution
- medicinal aerosol
- stabilized medicinal
- stabilized
- Prior art date
Links
- 239000000443 aerosol Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98785292A | 1992-12-09 | 1992-12-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA939195B true ZA939195B (en) | 1995-06-08 |
Family
ID=25533628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA939195A ZA939195B (en) | 1992-12-09 | 1993-12-08 | Stabilized medicinal aerosol solution formulations |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1054282C (en) |
| TW (1) | TW403657B (en) |
| ZA (1) | ZA939195B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ528640A (en) * | 2001-03-30 | 2004-06-25 | Jagotec Ag | Medical aerosol formulations |
| LT3494995T (en) * | 2002-03-01 | 2020-04-10 | Chiesi Farmaceutici S.P.A. | Formoterol superfine formulation |
| UA88894C2 (en) * | 2004-02-27 | 2009-12-10 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Stable pharmaceutical solution formulation for pressurized metered dose inhalers |
| CN101119706B (en) * | 2005-02-25 | 2013-04-17 | 奇斯药制品公司 | Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a chelating agent |
| CN105263473A (en) * | 2013-11-22 | 2016-01-20 | 梯瓦优质制药产品研发股份有限公司 | An inhalable medicament |
| US20160250197A1 (en) * | 2013-11-22 | 2016-09-01 | Teva Branded Pharmaceutical Products R&D, Inc. | An inhalable medicament |
| CN106038489B (en) * | 2016-05-25 | 2018-11-02 | 华润双鹤药业股份有限公司 | Ipratropium Bromide aerosol |
| CN111297835B (en) * | 2019-12-20 | 2022-11-25 | 上海方予健康医药科技有限公司 | Inhalation aerosol containing anticholinergic medicine and its preparation process and usage |
| CN113398102A (en) * | 2021-05-28 | 2021-09-17 | 北京达因高科儿童药物研究院有限公司 | Ipratropium bromide inhalation aerosol and preparation process thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8900267D0 (en) * | 1989-01-06 | 1989-03-08 | Riker Laboratories Inc | Narcotic analgesic formulations and apparatus containing same |
-
1993
- 1993-12-08 ZA ZA939195A patent/ZA939195B/en unknown
- 1993-12-09 CN CN93120173A patent/CN1054282C/en not_active Expired - Lifetime
- 1993-12-27 TW TW82111007A patent/TW403657B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1054282C (en) | 2000-07-12 |
| CN1095265A (en) | 1994-11-23 |
| TW403657B (en) | 2000-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG52459A1 (en) | Stabilized medicinal aerosol solution formulations | |
| IL101169A0 (en) | Pharmaceutical aerosol formulations | |
| ZA914957B (en) | Aerosol drug formulations | |
| IL92457A0 (en) | Medicinal aerosol formulations | |
| GB8921222D0 (en) | Medicinal aerosol formulations | |
| IL116460A0 (en) | Aerosol drug formulations | |
| EP0460064A4 (en) | Therapeutic aerosol formulations | |
| GB9118830D0 (en) | Medical aerosol formulations | |
| IL112897A0 (en) | Aerosol drug formulations containing vitamin e | |
| ZA939195B (en) | Stabilized medicinal aerosol solution formulations | |
| GB9201639D0 (en) | Pharmaceutical formulations | |
| GB9001019D0 (en) | Pharmaceutical aerosol | |
| ZA934523B (en) | Medicinal preparation | |
| ZA935119B (en) | Medicinal composition comprising TCF-II | |
| GB9222591D0 (en) | Medicinal remedy | |
| GB9221244D0 (en) | Pharmaceutical formulations | |
| GB9307003D0 (en) | Pharmaceutical formulations | |
| GB9204774D0 (en) | Pharmaceutical formulations | |
| GB9203212D0 (en) | Pharmaceutical formulations | |
| GB9217602D0 (en) | Pharmaceutical formulations | |
| GB9207338D0 (en) | Pharmaceutical formulations | |
| GB8920348D0 (en) | Medicinal aerosol formulations | |
| ZA9510754B (en) | Aerosol drug formulations | |
| GB9214102D0 (en) | Aerosol formulation | |
| GB9212968D0 (en) | Pharmaceutical formulation |